Brett W.Bell

Associate

Cleveland + 1.216.586.7097

Connect:

Share

Brett Bell represents corporate clients in complex antitrust, consumer protection, and shareholder lawsuits and in actions involving torts and breach of contract. He has litigated cases (including class actions) in state and federal courts across the country and has represented clients in government and criminal investigations.

Brett is an experienced antitrust litigator. He has defended U.S. and international clients in cases involving allegations of price-fixing, bid rigging, and monopolization, both in civil actions and in investigations brought by the Department of Justice. The antitrust clients he serves include companies in the automotive, technology, manufacturing, pharmaceutical, and health care industries.

Brett also has substantial experience defending clients in securities and shareholder derivative lawsuits. He has defended Fortune 500 companies in state and federal lawsuits seeking to enjoin public company mergers and in lawsuits alleging securities fraud or breaches of fiduciary duties.

Brett also has won dismissal at the pleading stage of several consumer class actions involving product labeling and allegedly defective products and successfully defended those victories on appeal.

Brett is a member of the Ohio State Bar Association (OSBA) and presents an annual CLE course on the Rule Against Hearsay during the OSBA's Trial Evidence for the Ohio Practitioner seminar. He maintains an active pro bono practice and has represented multiple clients in asylum proceedings before U.S. immigration courts. Brett also serves on the board of Youth Opportunities Unlimited, an organization dedicated to helping teens and young adults become economically self-sufficient contributors to Northeast Ohio's workforce through educational, career coaching, and workforce development programs.

Experience

  • Indivior resolves antitrust and fraud claimsJones Day resolved litigation filed by five insurance companies alleging that Indivior, Inc. had attempted to illegally monopolize the market for its prescription drug Suboxone.
  • Indivior resolves "product hop" allegations in antitrust class actionJones Day resolved multidistrict litigation brought against Indivior, Inc. Indivior manufactures the prescription drug, Suboxone, which is used to treat opioid addiction.
  • GOJO secures Ninth Circuit affirmation of PURELL® class action dismissalJones Day successfully defended on appeal a district court’s dismissal of all claims against GOJO Industries, Inc., the maker of PURELL® hand sanitizer products, in a putative class action filed in federal court in California.
  • Indivior obtains Third Circuit affirmation of dismissal of RICO, state law claimsOn December 15, 2022, the United States Court of Appeals for the Third Circuit ruled in favor of Jones Day clients Indivior Inc., Indivior Solutions Inc., and Indivior plc.
  • Chamberlain University obtains Sixth Circuit affirmance dismissing breach of contract lawsuitA Jones Day cross-office team secured a significant appellate victory in the Sixth Circuit for Chamberlain University, a nursing school with campuses in 15 states and a subsidiary of Adtalem Global Education.
  • Hardwood manufacturer obtains dismissal with prejudice in Southern District of CaliforniaJones Day successfully defended a manufacturer of hardwood flooring in a putative class action in the U.S. District Court for the Southern District of California, involving claims that client's flooring products are defective and that its advertising violates California's consumer protection laws.
  • GOJO defeats class actions alleging false advertising relating to Purell® hand sanitizersJones Day successfully defended GOJO Industries, Inc., the maker of Purell® hand sanitizer products, in multiple putative nationwide class actions.
  • Yazaki successfully resolves automaker lawsuit alleging price-fixing and bid riggingJones Day represented Yazaki Corporation and Yazaki North America, Inc. in successfully resolving a civil antitrust lawsuit brought by an automaker following Jones Day's filing of motions for summary judgment and to exclude the plaintiff's sole expert witness.
  • SiriusXM successfully defends lawsuit relating to trial subscribers' contact informationJones Day successfully defended and obtained affirmance on behalf of Sirius XM Radio Inc. in a putative class action alleging violations of the Driver's Privacy Protection Act ("DPPA").
  • Chevron buys Pasadena Refining System for $350 million from Petrobras America Inc.Jones Day advised Chevron U.S.A. Inc., a wholly-owned subsidiary of Chevron Corporation, in its purchase of all of the equity interests of Pasadena Refining System Inc. ("PRSI") and PRSI Trading, LLC from Petrobras America Inc. for $350 million, subject to adjustments for working capital.
  • CAE enforces antitrust claims and defends trade secret and copyright claims against Gulfstream Aerospace Corp.Jones Day successfully represented CAE Inc., a global leader in the development and manufacture of aviation flight simulators and pilot training programs, in enforcing antitrust claims and defending trade secret and copyright claims against Gulfstream Aerospace Corp. involving the Gulfstream G650 business jet.
  • Cliffs Natural Resources prevails in bondholder class actionJones Day represented Cliffs Natural Resources Inc. in a bondholder class action challenging a voluntary debt exchange offer that Cliffs Natural Resources conducted in early 2016.
  • Former board members of OM Group, Inc. defend shareholder litigationJones Day represented the former members of the board of directors of OM Group, Inc. in connection with shareholder litigation filed in Delaware Chancery Court arising out of the company's $1.03 billion acquisition by funds managed by affiliates of Apollo Global Management, LLC.
  • Cliffs Natural Resources and its directors defend shareholder challenges to actions in face of proxy fight for corporate controlJones Day defeated a motion for preliminary injunction and secured dismissal of claims of proxy violation and breach of fiduciary duty in a proxy contest on behalf of Cliffs Natural Resources Inc. and its directors.
  • Polypore sells the Company to Asahi Kasei for $3.2 billionJones Day advised Polypore International, Inc. (NYSE:PPO) in its definitive agreements for the sale of the Company to Asahi Kasei Corporation (TSE1:3407), through a U.S. subsidiary, for $60.50 per share in cash.
  • Cliffs Natural Resources defends multiple securities, derivative, and ERISA lawsuitsJones Day represented Cliffs Natural Resources, Inc. and various current and former officers and directors in a collection of securities (settled), derivative (settled), and ERISA (dismissed; affirmed on appeal) cases in state and federal court.
  • Explorys acquired by IBMJones Day advised Explorys, Inc. in connection with its merger with IBM.
  • Yazaki defends against automotive wire harness antitrust class actionsJones Day represents Yazaki North America and Yazaki Corporation in connection with numerous antitrust class action complaints alleging that Yazaki and other auto parts manufacturers violated the Sherman Act by engaging in bid-rigging and price-fixing in sales of automotive wire harnesses and related products.
  • Weiss Family acquires American Greetings for $878 millionJones Day advised the Weiss Family in its take private of American Greetings Corporation for approximately $878 million, including assumption of company's 7 3/8% Notes due 2021, which will remain outstanding after the transaction, the repayment of borrowings under the company's revolving credit facility, and the settlement of stock options not held by the Weiss Family.
    • View All

    Additional Speaking Engagements

    • October 25, 2019
      "Hearsay," Trial Evidence for the Ohio Practitioner, Ohio State Bar Association Live CLE

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.